Lupin launches Molnulup for COVID-19 treatment Medical Dialogues Bureau9 Jan 2022 12:00 PM ISTMumbai: Drugmaker Lupin on Friday said it has launched antiviral medication Molnupiravir under the brand name Molnulup in the country for the...
India to become hub for Covid-19 antiviral generic drugs: Fitch Medical Dialogues Bureau8 Jan 2022 3:03 PM ISTNew Delhi: India will become the largest global hub for Covid-19 antiviral general drug production after the drug controller granted emergency-use...
MSN to launch generic anti-COVID pill Molnupiravir Medical Dialogues Bureau8 Jan 2022 9:45 AM ISTNew Delhi: Pharmaceuticals firm MSN Group on Thursday said it will launch its generic anti-COVID-19 pill Molnupiravir under the brand 'Molulow' in...
Molnupiravir not a part of National Protocol due to safety concerns says ICMR Chief Balram Bharg Roshni Dhar7 Jan 2022 5:43 PM ISTOn going pandemic has increased the need of new treatments to manage the novel corona virus, newer drugs like Remedisivir, and Molnupiravir were...
Aurobindo Pharma launches COVID-19 drug Molnupiravir Medical Dialogues Bureau7 Jan 2022 9:00 AM ISTHYDERABAD: Aurobindo Pharma Limited has launched COVID-19 treatment drug Molnupiravir under brand name "Molnaflu" in India.Molnupiravir is for...
Molnupiravir has major safety concerns, hence not part of National Protocol: ICMR chief Balram Bhargava Medical Dialogues Bureau6 Jan 2022 11:44 AM ISTNew Delhi: Pointing out to some major saftey concerns including teratogenicity, mutagenicity and also potential to cause cartilage damage and muscle...
Dr Reddys to launch anti-COVID drug Molnupiravir under brand name Molflu at Rs 35 per capsule Medical Dialogues Bureau5 Jan 2022 3:53 PM IST"Molflu (Molnupiravir) is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high...
Can DCGI approved Molnupiravir bolster India's fight against COVID? Farhat Nasim3 Jan 2022 11:45 PM ISTNew Delhi: As countries prepare themselves to fight a possible 'next wave'. The new variant – Omicron has been making headline and a surge in Covid-19...
Health Bulletin 3/January/2022 Dr. Nandita Mohan3 Jan 2022 7:45 PM ISTHere are the Top Health stories of the dayIndia's Omicron count crosses 1,700-markNMC nod to DM cardiology course at PGIMS RohtakIn a major milestone...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 7:36 PM ISTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
Mankind Pharma unveils anti COVID 19 pill Molulife Roshni Dhar1 Jan 2022 10:45 AM ISTTaking a significant step towards countering COVID-19 in India, drug major Mankind Pharma has announced the launch of the oral anti- COVID pill...
Two oral antivirals receive FDA authorization for COVID-19 treatment Medha Baranwal31 Dec 2021 7:09 PM ISTUSA: As the number of Omicron cases continues to increase in India and worldwide, two recently approved antiviral pills could be a game-changer for...
